Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
26 October 2022 - 8:14AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16 UNDER
THE
SECURITIES EXCHANGE ACT OF 1934
For
the month of October 2022
Commission
File Number: 001-41115
GENENTA
SCIENCE S.P.A.
(Translation
of registrant’s name into English)
Via
Olgettina No. 58
20132
Milan, Italy
(Address
of Principal Executive Offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Other
Events
On
October 24, 2022, Genenta Science S.p.A. (the “Company”) issued a press release (the “Press Release”) announcing
the Company’s business update and financial results for the six months ended June 30, 2022. A copy of the Press Release is furnished
as Exhibit 99.1 hereto.
Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
GENENTA SCIENCE S.P.A. |
|
|
|
By: |
/s/
Richard B. Slansky |
|
Name: |
Richard B. Slansky |
|
Title: |
Chief Financial Officer |
Dated:
October 25, 2022
Genenta Science (NASDAQ:GNTA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Genenta Science (NASDAQ:GNTA)
Historical Stock Chart
From Jul 2023 to Jul 2024